Pyrazolo[1,5-a]pyrimidine-based inhibitors of HCV polymerase.
about
DNMT3A and IDH mutations in acute myeloid leukemia and other myeloid malignancies: associations with prognosis and potential treatment strategiesSynthesis, Structural Elucidation, and In Vitro Antitumor Activities of Some Pyrazolopyrimidines and Schiff Bases Derived from 5-Amino-3-(arylamino)-1H-pyrazole-4-carboxamidesAllosteric inhibition of the hepatitis C virus NS5B polymerase: in silico strategies for drug discovery and development.Structure-activity relationships in the development of allosteric hepatitis C virus RNA-dependent RNA polymerase inhibitors: ten years of research.Synthesis and characterization of celecoxib derivatives as possible anti-inflammatory, analgesic, antioxidant, anticancer and anti-HCV agents.Anti-inflammatory and antimicrobial activities of novel pyrazole analogues.
P2860
Pyrazolo[1,5-a]pyrimidine-based inhibitors of HCV polymerase.
description
2009 nî lūn-bûn
@nan
2009 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
name
Pyrazolo[1,5-a]pyrimidine-based inhibitors of HCV polymerase.
@ast
Pyrazolo[1,5-a]pyrimidine-based inhibitors of HCV polymerase.
@en
type
label
Pyrazolo[1,5-a]pyrimidine-based inhibitors of HCV polymerase.
@ast
Pyrazolo[1,5-a]pyrimidine-based inhibitors of HCV polymerase.
@en
prefLabel
Pyrazolo[1,5-a]pyrimidine-based inhibitors of HCV polymerase.
@ast
Pyrazolo[1,5-a]pyrimidine-based inhibitors of HCV polymerase.
@en
P2093
P1476
Pyrazolo[1,5-a]pyrimidine-based inhibitors of HCV polymerase.
@en
P2093
Alan B Cooper
Gerald W Shipps
Janeta Popovici-Muller
Kristin E Rosner
M Arshad Siddiqui
Meredith A Brown
Michael Cable
Patrick J Curran
P304
P356
10.1016/J.BMCL.2009.09.087
P407
P577
2009-09-25T00:00:00Z